DxS, Exosome to Collaborate on Cancer Dx Tests | GenomeWeb

NEW YORK (GenomeWeb News) – DxS and Exosome Diagnostics said today that they will collaborate on developing blood-based companion diagnostics for cancer gene mutations, such as KRAS, BRAF, and EGFR.

Under the collaboration, the firms will team DxS' Scorpions real-time PCR Mutation Test Kits with Exosome's xOS technology for harvesting nucleic acids from blood exosomes. The firms hope to develop test kits that will measure gene mutations in blood and predict patient response to targeted therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.